Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.42
-0.30-8.06%
Last update: Oct 13, 4:00 PM
Macrogenics Inc (MGNX) Stock Price, Quote, News & History
MGNXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Other companies in Macrogenics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Macrogenics has a consensus price target of $8.00.
The stock price for Macrogenics (NASDAQ: MGNX) is $3.44 last updated October 13, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Macrogenics.
Macrogenics does not have any upcoming earnings scheduled.
There is no upcoming split for Macrogenics.
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
